Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis. | Breast Cancer (Dove Med Press) | 2023 | 36926265 | PubTator, text mining | PubMed |
| The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism. | Front Oncol | 2023 | 36923439 | PubTator, text mining | PubMed |
| Prognostic value of cellular population data in patients with COVID-19. | Inform Med Unlocked | 2023 | 36919041 | PubTator, text mining | PubMed |
| Control of human cytomegalovirus replication by liver resident natural killer cells. | Nat Commun | 2023 | 36918610 | PubTator, text mining | PubMed |
| Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer. | Gland Surg | 2023 | 36915817 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| The prognostic and therapeutic potential of HO-1 in leukemia and MDS. | Cell Commun Signal | 2023 | 36915102 | PubTator, text mining | PubMed |
| Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma. | Biomol Biomed | 2023 | 36913701 | PubTator, text mining | PubMed |
| Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV. | Front Immunol | 2023 | 36911702 | PubTator, text mining | PubMed |
| Phenotypic diversity of human adipose tissue-resident NK cells in obesity. | Front Immunol | 2023 | 36911659 | PubTator, text mining | PubMed |
| Emerging Trends in Immunotherapy for Adult Sarcomas. | Oncologist | 2023 | 36905579 | PubTator, text mining | PubMed |
| Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis. | Front Endocrinol (Lausanne) | 2023 | 36896172 | PubTator, text mining | PubMed |
| Vinyl chloride enhances high-fat diet-induced proteome alterations in the mouse pancreas related to metabolic dysfunction. | Toxicol Sci | 2023 | 36892438 | PubTator, text mining | PubMed |
| Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma. | Front Genet | 2023 | 36891153 | PubTator, text mining | PubMed |
| Programmed Cell Death-1 (PD-1) anchoring to the GPI-linked co-receptor CD48 reveals a novel mechanism to modulate PD-1-dependent inhibition of human T cells. | Mol Immunol | 2023 | 36889184 | PubTator, text mining | PubMed |
| resVAE ensemble: Unsupervised identification of gene sets in multi-modal single-cell sequencing data using deep ensembles. | Front Cell Dev Biol | 2023 | 36875765 | PubTator, text mining | PubMed |
| The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function. | Hemasphere | 2023 | 36874381 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
| Bacterial meningitis in Africa. | Front Neurol | 2023 | 36864913 | PubTator, text mining | PubMed |
| Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response. | Microbiol Spectr | 2023 | 36861980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=25